tailieunhanh - Comparative effectiveness of 8 versus 12 weeks of Ombitasvir/Paritaprevir/ ritonavir and Dasabuvir in treatment-naïve patients infected with HCV genotype 1b with non-advanced hepatic fibrosis

The aim of our study was to assess the comparative efficacy of 8 and 12-weeks therapy with OPrD in large cohort of patients eligible for 8 weeks regimen treated in real-world setting. |

TỪ KHÓA LIÊN QUAN